The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells.
- Published in:
- Oncogenesis, 2021, v. 10, n. 9, p. 1, doi. 10.1038/s41389-021-00352-9
- By:
- Publication type:
- Article
Works matching IS 21579024 AND DT 2021 AND VI 10 AND IP 9
Results: 5
1
2
IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming.
- Published in:
- Oncogenesis, 2021, v. 10, n. 9, p. 1, doi. 10.1038/s41389-021-00349-4
- By:
- Publication type:
- Article
3
Suppression of 4.1R enhances the potency of NKG2D-CAR T cells against pancreatic carcinoma via activating ERK signaling pathway.
- Published in:
- Oncogenesis, 2021, v. 10, n. 9, p. 1, doi. 10.1038/s41389-021-00353-8
- By:
- Publication type:
- Article
4
Tripartite motif-containing 3 (TRIM3) enhances ER signaling and confers tamoxifen resistance in breast cancer.
- Published in:
- Oncogenesis, 2021, v. 10, n. 9, p. 1, doi. 10.1038/s41389-021-00350-x
- By:
- Publication type:
- Article
5
A CRISPR knockout screen reveals new regulators of canonical Wnt signaling.
- Published in:
- Oncogenesis, 2021, v. 10, n. 9, p. 1, doi. 10.1038/s41389-021-00354-7
- By:
- Publication type:
- Article